Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 54

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 54
---
 of the next ordinary Annual Shareholders Meeting. Detailed information on the proposed board members is provided in the invitation. 9.01 Mr. Ronen Twito as chairman of the Board of Directors: citizen of Israel, residing in Israel 9.02 Prof. Michel Revel as member of the Board of Directors: citizen of Israel, residing in Israel 9.03 Mr. Eran Iohan as member of the Board of Directors: citizen of Israel, residing in Israel 9.04 Ms. Liora Oren as member of the Board of Directors: citizen of Israel, residing in Israel 9.05 Ms. Tammy Galili as member of the Board of Directors: citizen of Israel, residing in Israel FOR AGAINST ABSTAIN (TO BE SIGNED ON REVERSE) NLS PHARMACEUTICS LTD. Extraordinary Meeting of Shareholders September 29, 2025 The undersigned, a shareholder of NLS Pharmaceutics Ltd., (the “Company”), hereby appoints KBT Treuhand AG Zurich as independent proxy; or (full name and address) as proxy of the undersigned, with full power of substitution, for and as in the name of the undersigned, to vote and otherwise act on behalf of the undersigned at the extraordinary general meeting of shareholders of the Company to be held on September 29, 2025, at the premises of Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zurich, Switzerland, at 4 p.m. CEST (10 a.m. EST), or at any adjournment(s) or postponement(s) thereof, with respect to all of the common shares of the Company (the “Shares”) which the undersigned would be entitled to vote, with all powers the undersigned would possess if personally present, provided said proxies are authorized and directed to vote as indicated with respect to the matter set forth below this Proxy. The undersigned herewith acknowledges all actions and declarations of his/her/its proxy or the substitutes as legally binding for him/her/it. All shares represented by properly executed proxies received prior to or at the Meeting and not revoked prior to, or at, the Meeting in accordance with the procedures described in the proxy statement, will be voted as specified in the instructions indicated in such proxies. Subject to applicable law, in the absence of instructions, the shares represented by properly executed and received proxies will be voted “FOR” all of the proposed resolutions to be presented at the Meeting for which the Board recommends